Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%221474-0338%22+OR+%221744-764X%22&type=ISN&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
/vufind/Search/Results?lookfor=%221474-0338%22+OR+%221744-764X%22&type=ISN&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
Search /vufind/Search2/Results?lookfor=%221474-0338%22+OR+%221744-764X%22&type=ISN&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
PubPharm (47)
1
Data mining and safety analysis of traditional immunosuppressive drugs : a pharmacovigilance investigation based on the FAERS database
enthalten in:
Expert opinion on drug safety
| 2024
von
Li, J.
|
Chen, L.
|
Zhao, Y.
| +3
Wird geladen...
2
The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands
enthalten in:
Expert opinion on drug safety
| 2024
von
Ouaddouh, C.
|
Duijster, J.
|
Lieber, T.
| +1
Wird geladen...
3
Post-marketing safety of anti-IL-5 monoclonal antibodies (mAbs) : an analysis of the FDA Adverse Event Reporting System (FAERS)
enthalten in:
Expert opinion on drug safety
| 2024
von
Zou, S.
|
Yang, H.
|
Ouyang, M.
| +3
Wird geladen...
4
Lessons learned from COVID-19, H1N1, and routine vaccine pharmacovigilance in the United States : a path to a more robust vaccine safety program
enthalten in:
Expert opinion on drug safety
| 2024
von
Salmon, D.
|
Chen, R.
|
Black, S.
| +1
Wird geladen...
5
Patterns of adverse drug reactions in Jordan : a retrospective analysis of the National Pharmacovigilance Data Registry (2015-2021)
enthalten in:
Expert opinion on drug safety
| 2023
von
Mhaidat, N.
|
Alshogran, O.
|
Altawalbeh, S.
| +4
Wird geladen...
6
Investigating the risk of deep vein thrombosis with JAK inhibitors : a disproportionality analysis using FDA Adverse Event Reporting System Database (FAERS)
enthalten in:
Expert opinion on drug safety
| 2023
von
Mytheen, S.
|
Varghese, A.
|
Joy, J.
| +2
Wird geladen...
7
A cross-sectional study on substandard and falsified medicines (fake or counterfeit drugs) in UK pharmacies during the COVID-19 pandemic
enthalten in:
Expert opinion on drug safety
| 2023
von
Barrett, R.
Wird geladen...
8
Proton pump inhibitors use prior to COVID-19 hospitalization is associated with higher Clostridioides difficile infection rate
enthalten in:
Expert opinion on drug safety
| 2023
von
Lucijanic, M.
|
Busic, N.
|
Stojic, J.
| +9
Wird geladen...
9
Drug-drug interaction of Nirmatrelvir/ritonavir and tacrolimus : A potential risk disproportionality analysis of nephrotoxicity from COVID-19 reports in FAERS
enthalten in:
Expert opinion on drug safety
| 2023
von
Qin, F.
|
Wang, H.
|
Li, M.
| +2
Wird geladen...
10
Evaluation of adverse events of bamlanivimab, bamlanivimab/etesevimab used for COVID-19 based on FAERS database
enthalten in:
Expert opinion on drug safety
| 2023
von
Zhao, Y.
|
Wang, H.
|
Zhang, Q.
| +3
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
47
Aufsätze
47
E-Artikel
47
E-Ressourcen
Zeitschriftentitel
47
Expert opinion on drug safety
Thema
25
Journal Article
18
COVID-19
11
pharmacovigilance
8
FAERS
7
Review
6
COVID-19 Vaccines
5
Antiviral Agents
5
Editorial
5
SARS-CoV-2
5
pandemic
4
remdesivir
4
safety
3
ISP4442I3Y
3
JAK inhibitor
3
Janus Kinase Inhibitors
3
Sulfonamides
3
adverse event
3
baricitinib
2
3QKI37EEHE
2
415SHH325A
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4
2024
12
2023
10
2022
13
2021
8
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
47
Englisch
Haven't found what you're looking for?
Wird geladen...